Cardiovascular Devices Market (By Device Type: Diagnostic & Monitoring and Surgical Devices; By Application: Cardiac Arrhythmia, Coronary Artery Disease, Heart Failure, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030


According to Precedence Research, the global cardiovascular devices market was valued at US$ 52.90 billion in 2021 and is expected to reach over US$ 92.51 billion by 2030 with a registered CAGR of 6.4% during the forecast period 2021 to 2030.

Cardiovascular Devices Market Size 2020 to 2030

Growth Factors

The global cardiovascular devices market is significantly driven by the growing prevalence of chronic cardiovascular diseases across the globe. According to the World Health Organization, cardiovascular diseases are the leading cause of death across the globe. Cardiovascular diseases results in around 17.9 million deaths each year, globally. The major causes of the cardiovascular diseases include high consumption of salt in diet, increased consumption of tobacco, rising prevalence of smoking, and higher alcohol consumption. The cardiovascular diseases can be treated effectively by detecting it early. Therefore, the rising demand for the early diagnosis of the cardiovascular diseases is expected to drive the growth of the global cardiovascular devices market. Moreover, an alarming rise in obese population and physical inactivity is increasing the risks of cardiovascular diseases, which is expected to augment the demand for the cardiovascular devices across the globe. Growing geriatric population across the globe is another major factor behind the market growth. The old age people have higher chances of developing cardiovascular related diseases. According to the United Nations, the global geriatric population is estimated to reach at around 2 billion by 2050.

The new product launches with innovative and new features is expected to boost the demand for the cardiovascular devices. For instance, in February 2021, Remo Care Solutions introduced a new AI based remote monitoring device for the cardiac patients that analyzes the cardiovascular conditions of the patients in real-time. The growing demand for the efficient and innovative cardiovascular devices to reduce the deaths related to the cardiovascular diseases is significantly driving the growth of the global cardiovascular devices market. Moreover, the integration of the latest technologies like artificial intelligence (AI) in the cardiovascular devices is improving the patient care services and reducing the mortality of the cardiac patients. The rising investments by the top market players in the development and clinical trials of advanced cardiovascular devices is opening new growth avenues that will foster the market growth in the forthcoming years.

Scope of the Cardiovascular Devices Market

Report Coverage Details
Market Size in 2020 USD 49.8 Billion
Growth Rate from 2021 to 2030 6.4%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Device, Application, Region
Companies Mentioned B Braun Melsungen AG, Abbott, Johnson & Johnson Services, Inc., Medtronic, Boston Scientific Corporation, LivaNova Plc, Edwards Lifesciences Corporation, GE Healthcare, Siemens Healthcare GmbH, Terumo Cardiovascular Systems Corporation

 

Device Type Insights

The therapeutics & surgical devices segment dominated the market with 74% revenue share in 2020. This is attributed to the increased number of bypass surgeries across the globe. The increased demand for the cardiac rhythm management devices, stents, and catheters has pumped the revenue generation of this segment. The increased awareness regarding the cardiovascular diseases and easy availability of the devices has fostered the segment’s growth.

Cardiovascular Devices Market Share, By Devices, 2020 (%)

On the other hand, the diagnostic and monitoring is estimated to be the most opportunistic segment during the forecast period. The rising demand for the early diagnosis of the cardiovascular diseases is fueling the growth of this segment. The rising awareness among the population regarding the benefits of the early detection of CVDs and effective treatment availability are the major factors behind the growth of the diagnosis and monitoring segment.

Application Insights

Based on the application, the coronary artery disease segment dominated the global cardiovascular devices segment in 2020. The increased prevalence of the coronary artery diseases has fueled the sales of the coronary stents in the market. The rising popularity of the stents in the treatment of coronary artery disease is expected to sustain the dominance of this segment throughout the forecast period.

The cardiac arrhythmia is estimated to be the most opportunistic segment during the forecast period. This is attributable to the rising demand for the pacemakers. The growing investments in the development of innovative pacemakers with innovative features are expected to drive the market growth in the upcoming years. For instance, Medtronic launched a pacemaker that has BlueSync technology, in India.

Region Insights

North America dominated the global cardiovascular devices market in 2020. The presence of several top manufacturers in the region along with the growing burden of cardiovascular diseases in US is augmenting the demand for the cardiovascular devices in the region. According to the American Heart Association, around 18.6 million deaths were associated with the cardiovascular diseases in US in 2019. The increased healthcare expenditure and improved access to the healthcare facilities has significant contributions in the market growth. Moreover, the higher adoption rate of the innovative healthcare devices among the population has driven the demand for various cardiovascular devices. The presence of developed and advanced healthcare infrastructure in North America coupled with the favorable reimbursement policies has fostered the demand for the various diagnostic devices and surgeries in North America.

Asia Pacific is estimated to be the fastest-growing market during the forecast period. Asia Pacific is characterized by the presence of huge population, rising prevalence of cardiovascular diseases, rising healthcare expenditure, and rising investments by the government towards the development of sophisticated healthcare infrastructure in the region that are expected to drive the growth of the cardiovascular devices market in the region. According to the World Health Organization, around 75% of the cardiovascular diseases related deaths occur in low and middle income countries. The rising accessibility to healthcare services and rising affordability are fueling the adoption of the cardiovascular devices in Asia Pacific region. Moreover, the rapidly growing geriatric population in the region is further expected to influence the demand for the cardiovascular devices. According to the United Nations, around 80% of the global geriatric population is expected to live in low and middle income countries by 2050.

Key Developments

  • In February 2021, Remo Care Solutions introduced a new AI based remote monitoring device for the cardiac patients that analyzes the cardiovascular conditions of the patients in real-time.
  • In April 2021, Phoenix Cardiac Devices received CE mark for its Basal Annuloplasty of the Cardio Externally device.
  • In December 2020, Philips acquired BioTelemetry, Inc. This will integrate the patient monitoring services of Philips with cardiac diagnostics and monitoring services of the BioTelemetry in hospitals.

The various developmental strategies like partnerships and new product launches fosters market growth and offers lucrative growth opportunities to the market players.

Some of the prominent players in the global cardiovascular devices market include:

  • B Braun Melsungen AG
  • Abbott
  • Johnson & Johnson Services, Inc.
  • Medtronic
  • Boston Scientific Corporation
  • LivaNova Plc
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • Siemens Healthcare GmbH
  • Terumo Cardiovascular Systems Corporation

Segments Covered in the Report

By Device Type

  • Diagnostic & Monitoring
  • Therapeutic & Surgical Devices

By Application

  • Cardiac Arrhythmia
  • Coronary Artery Disease
  • Heart Failure
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • MEA
  • Latin America
  • Rest of the World

Frequently Asked Questions

What is the current size of cardiovascular devices market?
Precedence Research Predicts, the global cardiovascular devices market was worth at US$ 49.8 billion in 2020 and is predicted to reach over US$ 92.51 billion by 2030.
The global cardiovascular devices market is growing at a CAGR of 6.4% during the forecast period 2021 to 2030.
The rising prevalence of various chronic cardiovascular diseases such as coronary artery disease, heart failure, and cardiac arrhythmia is fueling the growth of the cardiovascular devices market.
The major players operating in the cardiovascular devices market are B Braun Melsungen AG, Abbott, Johnson & Johnson Services, Inc., Medtronic, Boston Scientific Corporation, LivaNova Plc, Edwards Lifesciences Corporation, GE Healthcare, Siemens Healthcare GmbH, Terumo Cardiovascular Systems Corporation.
North America dominated the global cardiovascular devices in 2020. The increased prevalence of cardiovascular diseases in US has exponentially contributed towards the market growth in the past few years.

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample